 - Persistent toxicities Common Terminology Criteria for Adverse Event CTCAE grade 2 and neuropathy CTCAE grade 1 caused by previous cancer therapy, excluding alopecia - Patient with myelodysplastic syndrome MDSacute myeloid leukaemia AML or with features suggestive of MDSAML 